Studies in mice and humans indicate that membrane CD14 (mCD14) on the cell surface of monocytes, macrophages, and PMN mediates the activation of these cells by LPS. The soluble CD14 (sCD14) present in the circulation also binds to LPS and blocks LPS binding to mCD14. To determine the role of a recombinant bovine soluble CD14 polypeptide in cellular activation by LPS, a recombinant bovine soluble CD14 polypeptide, rbosCD14, was cloned and expressed in a baculovirus expression system. Results indicated that rbosCD14 inhibited the LPS-induced increase in CD18 expression and TNF mRNA in vitro and reduced mortality in mice injected with LPS. Further, rbosCD14 sensitized mammary epithelial cells to low concentrations of LPS resulting in recruitment of white blood cells and prevention of LPS-induced infection.

 
Web www.patentalert.com

< Pharmaceuticals and assays using enzyme subunits

< Nucleic acid molecule encoding a PANG6 polypeptide

> DNA construct comprising an FGF1B promoter region operably linked to an SV40 large T antigen encoding sequence

> Nucleic acids encoding peptides that induce chondrocyte redifferentiation

~ 00229